Cell Therapy Account Management - North Central
Nebraskaonsite$200K – $220K
via Greenhouse
About this role
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches.…
Read the full description on Iovance Biotherapeutics's site →
What we'd score you on
reqspace match rubricFive dimensions, recruiter-grade. Upload your resume and we'll generate a written explanation of where you fit and where the gaps are.
1
Skills match
For this role: teams
2
Level fit
We check your title trajectory against the seniority signal of the role.
3
Domain experience
Your work in the role's domain matters more than your years total. We weight recent and direct experience.
4
Recency
A skill you used last quarter weighs more than one from five years ago. We grade on recency, not lifetime.
5
Location fit
This role is based in Nebraska. We weight your proximity and willingness to relocate.
Score yourself on this role.
Free · no card · written explanation included
Skills in this role
Pulled from the job description. These are the keywords we'll weight when scoring your fit.
teams
More at Iovance Biotherapeutics
- View →Supervisor, Aseptic ManufacturingPhiladelphia, Pennsylvania
- View →Contract Statistical ProgrammerRemote
- View →Aseptic Manufacturing Technician I - Night Shift B [Contract to Hire]Philadelphia, PA
- View →Senior Manager, Clinical Supply PlanningHybrid
- View →Regulatory Affairs CMC Associate IIRemote
- View →Logistics & Planning Associate IIPhiladelphia
